
TKB Critical Technologies 1
NASDAQ:USCT
9.86 (USD) • At close June 17, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2025 Q1 | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q3 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cost of Revenue
| 0 | 0 | 0.06 | 0.186 | 0.269 | 0.319 | 0.46 | 0.76 | 2.877 | 2.336 | 0.314 | 0.328 | 0 | 0 |
Gross Profit
| 0 | 0 | 0 | 0 | -0.269 | -0.319 | -0.46 | -0.76 | -2.877 | -2.336 | -0.314 | -0.328 | 0 | 0 |
Gross Profit Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
General & Administrative Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.266 | 0.314 | 0.328 | 0.428 | 0.044 |
Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
SG&A
| 0 | 0 | 0 | 0 | 0 | 0.319 | 0.46 | 0.76 | 2.877 | 1.266 | 0.314 | 0.328 | 0.428 | 0.044 |
Other Expenses
| 0 | 0.135 | 0.06 | 0.186 | 0.269 | -7.652 | 0 | 4.65 | 3.002 | 0 | 0 | 0 | 0 | 0 |
Operating Expenses
| 0 | 0.135 | 0.06 | 0.186 | 0.269 | 0.319 | 0.46 | 0.76 | 3.002 | 1.266 | 0.314 | 0.328 | 0.428 | 0.044 |
Operating Income
| -0.387 | -0.135 | -0.06 | -0.186 | -0.269 | -0.319 | -0.46 | -0.76 | -2.877 | -1.266 | -0.314 | -0.328 | -0.428 | -0.044 |
Operating Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Other Income Expenses Net
| -0.89 | -0.196 | 0 | 0.417 | 0.548 | 1.56 | -0.807 | 8.045 | -1.795 | 3.059 | 3.282 | 4.324 | 2.916 | 0 |
Income Before Tax
| -1.277 | -0.331 | -0.06 | 0.231 | 0.279 | 1.241 | -1.267 | 7.285 | -4.672 | 1.793 | 2.968 | 3.996 | 2.488 | -0.044 |
Income Before Tax Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Income Tax Expense
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.795 | -3.059 | -3.282 | -4.324 | -2.916 | 0 |
Net Income
| -1.277 | -0.331 | -0.06 | 0.231 | 0.279 | 1.241 | -1.267 | 7.285 | -6.466 | 4.852 | 6.25 | 8.32 | 5.404 | -0.044 |
Net Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EPS
| -0.16 | -0.42 | -0.01 | 0.034 | 0.036 | 0.158 | -0.157 | 0.649 | -0.417 | 0.062 | 0.103 | 0.139 | 0.087 | -0.002 |
EPS Diluted
| -0.16 | -0.42 | -0.01 | 0.034 | 0.036 | 0.158 | -0.157 | 0.649 | -0.417 | 0.062 | 0.103 | 0.139 | 0.087 | -0.002 |
EBITDA
| -0.387 | 0.634 | -0.06 | -0.186 | -0.269 | -0.319 | -0.46 | -0.76 | -0.147 | -1.266 | -0.314 | -0.328 | -0.428 | -0.044 |
EBITDA Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |